Southeast Asset Advisors’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,441
Closed -$1.02M 151
2022
Q1
$1.02M Buy
5,441
+76
+1% +$14.4K 0.14% 75
2021
Q4
$1.42M Buy
5,365
+84
+2% +$22.6K 0.2% 67
2021
Q3
$1.53M Buy
5,281
+68
+1% +$17.4K 0.25% 65
2021
Q2
$1.04M Buy
5,213
+80
+2% +$15.5K 0.17% 74
2021
Q1
$998K Buy
5,133
+5
+0.1% +$1.02K 0.18% 70
2020
Q4
$983K Buy
5,128
+30
+0.6% +$5.46K 0.2% 68
2020
Q3
$752K Buy
5,098
+1,787
+54% +$255K 0.17% 71
2020
Q2
$409K Buy
+3,311
New +$390K 0.1% 91

Other funds holding RGEN

Southeast Asset Advisors's RGEN Position: Q2 2022 in Review

Southeast Asset Advisors sold out of Repligen (RGEN) in Q2 2022, closing a stake of 5,441 shares — an estimated $1.02M sold.

Southeast Asset Advisors first reported a position in RGEN in Q2 2020 and held it in 8 quarters. The position peaked at $1.53M in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

  • Southeast Asset Advisors reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
  • Southeast Asset Advisors sold 5,441 Repligen shares in Q2 2022, an estimated $1.02M.
  • Southeast Asset Advisors first reported a position in Repligen in Q2 2020 and held it in 8 quarters.
  • Southeast Asset Advisors's Repligen position peaked at $1.53M in Q3 2021.
  • 405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Southeast Asset Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.